In the supplementary materials for consolidated results for the fiscal year ending December 2025, a correction was made to a calculation error in the consolidated cash flow statement regarding acquisition expenditures for tangible fixed assets. Revenue was 496.8 billion yen, core operating income was 103.1 billion yen, and net income was 67.0 billion yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4151","jir_company_name":"Kyowa Kirin Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-03-09","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/4151-20260309-02.pdf","jir_short_summary":"In the supplementary materials for consolidated results for the fiscal year ending December 2025, a correction was made to a calculation error in the consolidated cash flow statement regarding acquisition expenditures for tangible fixed assets. Revenue was 496.8 billion yen, core operating income was 103.1 billion yen, and net income was 67.0 billion yen.","jir_summary":"### Performance Overview\nKyowa Kirin Co., Ltd. issued a correction in the supplementary materials for the financial summary of the fiscal year ending December 2025 due to an error in calculation related to \"expenditures for acquisition of tangible fixed assets\" in the consolidated cash flow statement. Revenue was 496.8 billion yen, nearly flat year-over-year; core operating income rose 8% year-over-year to 103.1 billion yen; and net income increased 12% to 67.0 billion yen. Research and development expenses were 101.2 billion yen, down 2% year-over-year, with an R&D expense ratio of 20.4%. Capital expenditures amounted to 35.8 billion yen for tangible fixed assets and 48.1 billion yen for intangible assets.\n\n### Segment Revenue and Product Trends\nIn regional revenue breakdown, overseas sales ratio reached 74%, with North America as the largest market recording 211.0 billion yen and EMEA at 78.5 billion yen. Among key products, Crysvita posted sales of 216.4 billion yen, up 9% year-over-year, and Poteligeo increased 20% to 45.7 billion yen. Technology income also showed an upward trend, reaching 48.8 billion yen. The number of employees was 5,161, down 508 compared to the previous year, reflecting progressed efficiency improvements.","jir_financial_highlights":"Revenue: 496.8 billion yen (Year-over-Year +0%)\nCore Operating Income: 103.1 billion yen (Year-over-Year +8%)\nNet Income (Quarterly): 67.0 billion yen (Year-over-Year +12%)\nResearch and Development Expenses: 101.2 billion yen (Year-over-Year -2%)\nCapital Expenditures (Tangible Fixed Assets): 35.8 billion yen (2025 results) (Unknown)\nNumber of Employees (End of December 2025): 5,161 persons (Year-over-Year -508 persons)","jir_category":"","jir_hashtags":"#KyowaKirinCoLtd, #FinancialSummary, #financial_summary, #JapaneseStocks","jir_key_figures":"Revenue: 496.8 billion yen (Fiscal Year Ending December 2025)\nCore Operating Income: 103.1 billion yen (Year-over-Year +8%)\nNet Income (Quarterly): 67.0 billion yen (Year-over-Year +12%)","jir_meta_title":"Kyowa Kirin Correction to 2025 Fiscal Year Financial Supplement - Revenue \u00a5496.8 Billion, Core Operating Income \u00a5103.1 Billion","jir_meta_description":"Kyowa Kirin Co., Ltd. announced partial corrections to supplementary financial materials for the fiscal year ending 2025. Achieved revenue of \u00a5496.8 billion, core operating income of \u00a5103.1 billion, and net income of \u00a567.0 billion with year-over-year increases in sales and profits.","jir_og_title":"Kyowa Kirin Announces Correction to 2025 Fiscal Year Financial Supplement","jir_og_description":"Issued supplementary materials including corrections to the consolidated cash flow statement for fiscal year ending 2025. Reported revenue of \u00a5496.8 billion and core operating income of \u00a5103.1 billion.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend (Billion Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Jan-Mar 2024\\\",\\\"Apr-Jun 2024\\\",\\\"Jul-Sep 2024\\\",\\\"Oct-Dec 2024\\\",\\\"Jan-Mar 2025\\\",\\\"Apr-Jun 2025\\\",\\\"Jul-Sep 2025\\\",\\\"Oct-Dec 2025\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[1056,1274,1298,1328,1047,1259,1188,1474],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Core Operating Income Trend (Billion Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Jan-Mar 2024\\\",\\\"Apr-Jun 2024\\\",\\\"Jul-Sep 2024\\\",\\\"Oct-Dec 2024\\\",\\\"Jan-Mar 2025\\\",\\\"Apr-Jun 2025\\\",\\\"Jul-Sep 2025\\\",\\\"Oct-Dec 2025\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Core Operating Income\\\",\\\"data\\\":[179,267,323,226,112,256,292,438],\\\"borderColor\\\":\\\"#8e5ea2\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Regional Revenue Breakdown (Billion Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Japan\\\",\\\"North America\\\",\\\"EMEA\\\",\\\"Others\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Fiscal Year 2025 Results\\\",\\\"data\\\":[1288,2110,785,1190],\\\"backgroundColor\\\":[\\\"#3cba9f\\\",\\\"#e8c3b9\\\",\\\"#c45850\\\",\\\"#8e5ea2\\\"]}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"product_revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Major Product Revenue Trend (Crysvita, Poteligeo) (Billion Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Jan-Mar 2024\\\",\\\"Apr-Jun 2024\\\",\\\"Jul-Sep 2024\\\",\\\"Oct-Dec 2024\\\",\\\"Jan-Mar 2025\\\",\\\"Apr-Jun 2025\\\",\\\"Jul-Sep 2025\\\",\\\"Oct-Dec 2025\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Crysvita\\\",\\\"data\\\":[378,530,440,617,424,573,469,697],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false},{\\\"label\\\":\\\"Poteligeo\\\",\\\"data\\\":[86,104,100,108,98,118,121,120],\\\"borderColor\\\":\\\"#e8c3b9\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"research_development_expense_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Research and Development Expense Trend (Billion Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Jan-Mar 2024\\\",\\\"Apr-Jun 2024\\\",\\\"Jul-Sep 2024\\\",\\\"Oct-Dec 2024\\\",\\\"Jan-Mar 2025\\\",\\\"Apr-Jun 2025\\\",\\\"Jul-Sep 2025\\\",\\\"Oct-Dec 2025\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"R&D Expenses\\\",\\\"data\\\":[233,259,250,293,286,239,243,243],\\\"borderColor\\\":\\\"#c45850\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":7472,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-33965","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n